EXHIBIT 11.1
PARACELSUS HEALTHCARE CORPORATION
COMPUTATION OF EARNINGS PER SHARE
(In thousands, except per share data)
Three Months Ended Nine Months Ended
September 30, September 30,
----------------- -----------------
1997 1996 1997 1996
------- ------ ------ ------
Primary:
- -------
(1) Net income (loss) $ 138 $(69,101) $ 2,289 $(88,612)
====== ====== ===== ======
Shares used in this computation:
Weighted average common
shares outstanding 55,016 42,290 54,892 33,975
Shares applicable to stock
options and warrants, net
of shares assumed to be
purchased from proceeds at
average market price 2,694 (a) 1,860 (a)
------ ------ ------ -------
(2) Total shares for net income
per share computation 57,710 42,290 56,752 33,975
====== ====== ====== ======
Income (loss) per share:
Continuing operations $ - $ (1.08) $ 0.04 $ (1.46)
Discontinued operations - (0.45) - (1.01)
Extraordinary loss - (0.10) - (0.14)
------ ------ ------ -----
Net Income (loss) per share
(1 divided by 2) $ - $ (1.63) $ 0.04 $ (2.61)
====== ==== ====== =====
Fully Diluted:
- -------------
(3) Net income (loss) (1) $ 138 $(69,101) $ 2,289 $(88,612)
====== ====== ===== ======
Shares used in this computation:
Total primary shares (2) 57,710 42,290 56,752 33,975
Shares applicable to stock
options and warrants in addition
to those used in primary
computation due to the use of
period-end marker price when
higher than average 150 (a) 50 (a)
------ ------ ------ ------
(4) Total fully diluted shares 57,860 42,290 56,802 33,975
====== ====== ====== ======
Income (loss) per share:
Continuing operations $ - $ (1.08) $ 0.04 $ (1.46)
Discontinued operations - (0.45) - (1.01)
Extraordinary loss - (0.10) - (0.14)
----- ----- ---- -----
Net Income (loss) per share
(3 divided by 4) $ - $ (1.63) $ 0.04 $ (2.61)
===== ===== ==== =====
(a) The effect of options and warrants were anti-dilutive for the quarter and
nine months ended September 30, 1996.